Oxidative Stress and Hemodialysis Access Failure
Completed
Conditions studied: End Stage Renal Disease, Hemodialysis
In brief
Complications of hemodialysis access are the most frequent single reason for hospitalization among patients with End Stage Renal Disease (ESRD). Uremia, and particularly uremia in patients with diabetes, is a state of increased oxidative stress. The central hypothesis to be tested by this project is that oxidative stress is a major (and modifiable) trigger for vascular access complications. We hope to slow or reduce rates of stenosis, thrombosis and access complications by giving Vitamin E supplementation to patients being treated by hemodialysis.
Key facts
- Study ID
- NCT00410449
- Run by
- National Institute of Environmental Health Sciences (NIEHS)
- People needed
- 35
- Starts
- 2001-05-01
- Expected to finish
- 2004-05-01
- Last updated by the study team
- 2015-10-06
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults, end stage renal disease treated by hemodialysis, patent hemodialysis vascular access (graft or fistula)
You may not qualify if…
- Temporary catheter dialysis access, inability to be compliant with study medication
Where it is running
- Center for Dialysis Care — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.